Price dualization for cervical cancer vaccines will be decided in April

Published: 2016-04-05 10:21:34

Updated: 2016-04-05 10:21:34

The selection of price dualization for cervical cancer vaccines, which was planned to be finished by March, has been delayed to April.

On the 31^st, the Korea Centers for Disease Control and Prevention(KCDC) announced postponement of the dualization and final pricing for ‘Gardasil’ and ‘Cervarix,’ cervical cancer vaccines, to April.

Previously, the KCDC announced plans to decide whether to d...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.